Naltrexone And Bupropion
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
Orexigen Therapeutics, Inc · Phase 2/3 · Completed · Enrollment 3
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Naltrexone/Bupropion | 0 participants | 0 participants | 0 participants | n/r | 0 |
| Placebo | 0 participants | 0 participants | 0 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.